A comprehensive view of Alexion Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Verge Genomics partners with AstraZeneca's Alexion in US$42M, four-year deal to use Verge's AI-enabled Converge drug discovery engine to find new targets for rare neurodegenerative diseases
Published:
September 08, 2023
by FierceBiotech
|
Ask us about our Tissue & Hygiene market view